Putting the Patient at the Center: FDA’s New Series Premiers with ME/CFS

It’s rare that ME/CFS as a disease category experiences a “first” that’s positive. Here’s one worth celebrating: the March 11, 2013 announcement by the Food & Drug Administration (FDA) that ME/CFS would be the first condition explored through the agency’s Patient-Focused Drug Development Initiative. In most of the regulatory framework that guides FDA decisions, information about […]

Read More

CFS Advisory Committee Meeting Summary

By Jennifer M. Spotila, J.D. The Chronic Fatigue Syndrome Advisory Committee (CFSAC) held its second 2011 meeting on November 8 and 9 in Washington, D.C.  The CFSAC provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health on issues related to chronic fatigue syndrome  (CFS). CFIDS Association President […]

Read More

CFS Advisory Committee Meets May 22-23

The federal Chronic Fatigue Syndrome Advisory Committee (CFSAC) meets next on May 22-23, 2013 in Washington, D.C. This chartered advisory committee provides advice and recommendations to the Secretary of Health and Human Services (HHS) through the Assistant Secretary for Health on issues related to ME/CFS. Here is the Federal Register notice announcing the meeting: http://1.usa.gov/15g9vA5. […]

Read More